Roth Capital Has Bearish Forecast for CVE:HIV Q2 Earnings

HIVE Blockchain Technologies Ltd. (CVE:HIVFree Report) – Research analysts at Roth Capital lowered their Q2 2026 EPS estimates for HIVE Blockchain Technologies in a research report issued to clients and investors on Wednesday, November 5th. Roth Capital analyst D. Aftahi now forecasts that the company will post earnings per share of ($0.06) for the quarter, down from their previous estimate of ($0.01). Roth Capital also issued estimates for HIVE Blockchain Technologies’ Q3 2026 earnings at ($0.11) EPS, Q4 2026 earnings at ($0.11) EPS, FY2026 earnings at ($0.44) EPS, Q1 2027 earnings at ($0.06) EPS, Q2 2027 earnings at ($0.04) EPS, Q3 2027 earnings at ($0.06) EPS, Q4 2027 earnings at $0.01 EPS and FY2027 earnings at ($0.14) EPS.

HIVE Blockchain Technologies Stock Performance

HIVE Blockchain Technologies Ltd. is a business services company in the Business Services industry.

Featured Articles

Earnings History and Estimates for HIVE Blockchain Technologies (CVE:HIV)

Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.